Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
This study revealed a substantial variation between European countries and regions in the early diffusion of biopharmaceuticals and the availability of data to monitor their use. The reasons behind these patterns require further investigation to support European countries in optimizing the use of biopharmaceuticals to reach an equitable and cost-effective use of medicines across Europe.
Authors
- Gisbert Selke (ORCID: https://orcid.org/0000-0002-9614-9875)
- Carlotta Lunghi (ORCID: https://orcid.org/0000-0001-7636-6285)
- Irina Iaru (ORCID: https://orcid.org/0000-0002-8011-3261)
- Tomáš Tesař (ORCID: https://orcid.org/0000-0002-0023-4574)
- Kristina Garuolienė (ORCID: https://orcid.org/0000-0001-7910-0108)
- Carla Torre (ORCID: https://orcid.org/0000-0002-5542-9993)
- Katarina Gvozdanović (ORCID: https://orcid.org/0000-0002-7943-3030)
- Tanja Mueller (ORCID: https://orcid.org/0000-0002-0418-4789)
- Guenka Ivanova Petrova (ORCID: https://orcid.org/0000-0001-8116-5138)
- Elita Poplavska (ORCID: https://orcid.org/0000-0002-9649-2120)
- Freyja Jónsdóttir (ORCID: https://orcid.org/0000-0002-9232-6723)
- Amanj Baker Kurdi (ORCID: https://orcid.org/0000-0001-5036-1988)
- Caridad Pontes (ORCID: https://orcid.org/0000-0002-3274-6048)
- Björn Wettermark (ORCID: https://orcid.org/0000-0003-0531-2516)
- Leena Saastamoinen (ORCID: https://orcid.org/0000-0002-0887-0137)
- Stuart McTaggart (ORCID: https://orcid.org/0000-0001-6060-9019)
- Ria Benkő (ORCID: https://orcid.org/0000-0002-8009-8962)
- Ott Laius (ORCID: https://orcid.org/0000-0003-3828-1373)
- Thais de Pando (ORCID: https://orcid.org/0009-0002-9238-5560)
- Juraj Slabý
- Edel Burton (ORCID: https://orcid.org/0000-0002-5847-0174)
- Katri Aaltonen (ORCID: https://orcid.org/0000-0002-1737-264X)
- Zornitsa Emilova Mitkova (ORCID: https://orcid.org/0000-0003-0782-200X)
- Agnese Cangini (ORCID: https://orcid.org/0000-0002-1640-3993)
- Irene Langner (ORCID: https://orcid.org/0000-0002-2951-3921)
- Irina Odnoletkova (ORCID: https://orcid.org/0000-0001-5224-1250)
- Brian Godman (ORCID: https://orcid.org/0000-0001-6539-6972)
- António Teixeira Rodrigues (ORCID: https://orcid.org/0000-0002-8161-9264)
- Ivar Veszelei
- Silvija Žiogaitė (ORCID: https://orcid.org/0009-0004-2769-0598)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Uppsala University (SE)
- University of Lisbon (PT)
- University of Turku (FI)
- University of Iceland (IS)
- St George's, University of London (GB)
- Vilnius University (LT)
- University of Strathclyde (GB)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- University of Szeged (HU)
- University College Cork (IE)
- Social Insurance Institution (FI)
- Bon Secours Hospital Cork (IE)
- Hospital de Sant Pau (ES)
- Sefako Makgatho Health Sciences University (ZA)
- Medical University of Sofia (BG)
- Servei de Salut de les Illes Balears (ES)
- Associacao Protectora dos Diabeticos de Portugal (PT)
- National University Hospital of Iceland (IS)
- Italian Medicines Agency (IT)
- Public Health Scotland (GB)
- Riga Stradiņš University (LV)
- Belgian Health Care Knowledge Centre (KCE) (BE)
- Andrija Stampar Teaching Institute of Public Health (HR)
- Finnish Medicines Agency Fimea (FI)
- Institut Català de la Salut (ES)
- Wissenschaftliches Institut der AOK (DE)
- State Institute for Drug Control (CZ)
- Link Campus University (IT)
- Comenius University Bratislava (SK)
- University of Bologna (IT)
- University of Minho (PT)
Publication Details
- Journal
- BioDrugs
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1007/s40259-025-00732-2
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Uppsala Universitet